Rosetta Genomics Regains Nasdaq Compliance

Because its stock has had a closing bid of at least $1 per share for 10 consecutive trading days, Rosetta Genomics will remain listed on the Nasdaq Capital Market.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories